JBZ-001
Advanced Solid Tumors and Non-Hodgkin Lymphoma
Phase 1Active
Key Facts
Indication
Advanced Solid Tumors and Non-Hodgkin Lymphoma
Phase
Phase 1
Status
Active
Company
About Jabez Biosciences
Jabez Biosciences is a private, pre-revenue biotech advancing a novel '3-S' framework for oncology drug development, prioritizing patient-friendly, manufacturable, and combination-ready therapies. The company's lead asset, JBZ-001, is in Phase 1, demonstrating its model's initial validation. Led by a seasoned team with extensive drug development experience, Jabez is actively raising capital through a Reg A+ offering to fund clinical milestones and pipeline expansion.
View full company profile